首頁 › 頭頸部鱗狀細胞癌 › 維吉尼亞州 › Arlington
Arlington, VA 的 頭頸部鱗狀細胞癌 臨床試驗
26 項針對 頭頸部鱗狀細胞癌 的研究正在 Arlington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
招募中1 期
- Site 04, Fairfax · 距離 11 英里
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
招募中1 期
- ALX Center 2, Fairfax · 距離 11 英里
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
招募中2 期
- Inova Fairfax Hospital, Falls Church · 距離 4 英里
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
- Inova Fair Oaks Hospital, Fairfax · 距離 11 英里
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
招募中1/2 期
- NEXT Oncology, Fairfax · 距離 11 英里
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
招募中2 期
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
招募中1/2 期
- Research Site, Fairfax · 距離 11 英里
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
招募中1 期
- Normunity Investigational Site, Fairfax · 距離 11 英里
A Study of DM005 in Patients With Advanced Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- USO-Virginia Cancer Specialists, PC, Fairfax · 距離 11 英里
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- NEXT, Fairfax · 距離 11 英里
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 距離 11 英里
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- NEXT Texas LLC - Virginia, Fairfax · 距離 11 英里
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距離 11 英里
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Fairfax · 距離 11 英里
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
招募中1 期
- NEXT Oncology, Fairfax · 距離 11 英里
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 102, Fairfax · 距離 11 英里
- Research Site 112, Fairfax · 距離 11 英里
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
其他城市的 頭頸部鱗狀細胞癌 試驗
- Houston, TX47 項研究
- Los Angeles, CA42 項研究
- Boston, MA40 項研究
- Nashville, TN39 項研究
- New York City, NY39 項研究
- St. Louis, MO28 項研究
- Chicago, IL26 項研究
- Philadelphia, PA26 項研究
- Atlanta, GA24 項研究
- San Antonio, TX22 項研究
- Pittsburgh, PA22 項研究
- New Haven, CT22 項研究
Arlington 的其他研究
- 非小細胞肺癌104 項研究
- 轉移性癌症53 項研究
- 大腸直腸癌52 項研究
- 癌症（所有類型）48 項研究
- 乳癌47 項研究
- 卵巢癌46 項研究
- 肺癌41 項研究
- 子宮內膜癌39 項研究
- 胰臟癌33 項研究
- 小細胞肺癌23 項研究
- 胃癌20 項研究
- 三陰性乳癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。